Organization
University Pierre & Marie Curie and Inserm, DHU i2B, APHP, Hospital Saint-Antoine, Paris, France
1 abstract
Abstract
A PHASE 2A, PLACEBO-CONTROLLED, RANDOMIZED STUDY OF ABT-981, AN ANTI-INTERLEUKIN-1ALPHA AND -1BETA DUAL VARIABLE DOMAIN IMMUNOGLOBULIN, TO TREAT EROSIVE HAND OSTEOARTHRITIS (EHOA) Org: Leiden University Medical Center, Leiden, Netherlands, Spire Sciences, Inc., Boca Raton, FL, United States, Diakonhjemmet Hospital, Oslo, Norway, AbbVie Inc., North Chicago, IL, University of Texas Southwestern Medical Center at Dallas, Metroplex Clinical Research Center, Dallas, TX, United States,